About Relic Biotechnology Private Limited
Data last updated:
Relic Biotechnology Private Limited is a private limited company based in Pune, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 11 January 2010 and has been in existence for over 16 years.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U01110PN2010PTC135294. Its GSTIN is 27AAECR5889D1Z0 (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Suvendu Kumar Patel and Tejraj Patel.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at E – 20 5th Floor Royal Arcade Opp. Deccan Honda Showroom Pune – Satara, Road, Maharashtra, India – 411043.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.09 Cr, a decline of 8% compared to the previous year. For the same year it recorded a net profit of ₹2.84 Lakh (net margin 1.4%) and EBITDA of ₹4.84 Lakh (EBITDA margin 2.3%). Revenue has declined at a compounded annual rate (CAGR) of 6% over three years and 4% over five years.
The company is associated with 1 brand: Relic Biotechnology. Court records list 3 cases involving the company, including 3 filed by the company; 2 cases are pending.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website relicbiotech.com.
Company details
Contact details
Relic Biotechnology Private Limited's registered office is in Pune, Maharashtra. Its website is relicbiotech.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressE – 20 5th Floor Royal Arcade Opp. Deccan Honda Showroom Pune – Satara, Road, Maharashtra, India – 411043
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Relic Biotechnology Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Relic Biotechnology operates one associated brand: Relic Biotechnology. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical company focused on oncology products and cancer care support services. | relicbiotech.com |
Business activity
The main business activity of Relic Biotechnology is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Relic Biotechnology Private Limited, buy the company report.
Financials of Relic Biotechnology Private Limited
FY 2025 filings availableRelic Biotechnology Private Limited reported revenue of ₹2.09 Cr (down 8% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 4% over five years, including a 8% fall in the latest year. EBITDA fell 22% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹4.84 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2.84 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.3% | ||||
| Net Profit Margin | 1.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Relic Biotechnology Private Limited, buy the company report.
Board of directors of Relic Biotechnology Private Limited
Relic Biotechnology has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Suvendu Kumar Patel Also directs: Relic Food & Beverage Private Limited | Director | 11 Jan 2010 | 16 Years 9 Months | Current |
| Tejraj Patel Also directs: Relic Food & Beverage Private Limited | Director | 11 Jan 2010 | 16 Years 9 Months | Current |
Peer comparison
Relic Biotechnology Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Biotechnology, Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Zydus Technologies Limited | ₹2.09 Cr (FY 2019) | Ahmedabad, Gujarat, India | ||||
| Relic Biotechnology Private Limitedthis company | ₹2.09 Cr (FY 2025) | ₹2.84 Lakh | 1.4% | -8.0% | Pune, Maharashtra, India | |
| Phenix Pharma Private Limited | ₹2.09 Cr (FY 2022) | -31.0% | Vadodara, Gujarat, India | |||
| Seven Hiills Softgel Private Limited | ₹2.08 Cr (FY 2021) | 20.0% | Hyderabad, Telangana, India | |||
| Zebx Pharmaceuticals Private Limited | ₹2.08 Cr (FY 2025) | 492.0% | Aramane Nagar, Karnataka, India | |||
| Nine Labs Private Limited | ₹2.08 Cr (FY 2025) | -34.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Relic Biotechnology Private Limited, buy the company report.
Auditor
Relic Biotechnology Private Limited is audited by A N GAWADE & CO for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| A N GAWADE & CO | FY 2021 | 122158W |
Shareholding
The shareholding of Relic Biotechnology Private Limited is on record for 4 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 | FY 2017 | FY 2016 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Relic Biotechnology Private Limited, buy the company report.
Legal cases
Relic Biotechnology Private Limited has 3 court cases on record: 3 filed by Relic Biotechnology. 2 cases are pending and 1 is disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 3 | 0 | 2 |
Cases on record (3 of 3)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Pune, Maharashtra | Civil suit | Filed by the company against Anand Enterprises Through Snehal Dnyaneshwar Narahare and 1 other | Pending |
| District court, Pune, Maharashtra | Criminal miscellaneous application | Filed by the company against M/S Wayright Pharma and 1 other | Pending |
| District court, Pune, Maharashtra | Court case (Spl.Sum.Suit) | Filed by the company against an individual | Disposed |
To see the full case history of Relic Biotechnology Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Relic Biotechnology Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Relic Biotechnology has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAECR5889D1Z0 | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Relic Biotechnology Private Limited, buy the company report.
Recent activity
Relic Biotechnology Private Limited has 2 board changes on record since 2010: 2 appointments. The latest: Suvendu Kumar Patel was appointed as Director on 11 Jan 2010.
Frequently asked questions
Relic Biotechnology is an active private limited company based in Pune, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 11 January 2010 (16+ years old) and is registered under CIN U01110PN2010PTC135294.
Relic Biotechnology has 2 current directors:
- Suvendu Kumar Patel - Director
- Tejraj Patel - Director
The latest financial statements of Relic Biotechnology on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Relic Biotechnology is 27AAECR5889D1Z0, registered in Maharashtra.
The CIN (Corporate Identification Number) of Relic Biotechnology is U01110PN2010PTC135294. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Relic Biotechnology has 3 court cases on record: 3 filed by the company. 2 are pending.
Relic Biotechnology was incorporated on 11 January 2010, making it 16+ years old. It is registered with the Registrar of Companies, Pune.
The peers of Relic Biotechnology by revenue are Zydus Technologies Limited, Phenix Pharma Private Limited, Seven Hiills Softgel Private Limited, Zebx Pharmaceuticals Private Limited, Nine Labs Private Limited, all in the Pharma industry (Biotechnology, Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Suvendu Kumar Patel was appointed as Director on 11 Jan 2010. Tejraj Patel was appointed as Director on 11 Jan 2010.
Relic Biotechnology can be reached through the website relicbiotech.com. Its registered office is in Pune, Maharashtra, India.
The registered office of Relic Biotechnology is at E – 20 5th Floor Royal Arcade Opp. Deccan Honda Showroom Pune – Satara, Road, Maharashtra, India – 411043.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
